Guardant Health, Inc. (GH) Amortization of Intangible Assets USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Guardant Health, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from 2018 to 2024.
  • Guardant Health, Inc. Amortization of Intangible Assets for the quarter ending March 31, 2024 was $700 K, unchanged year-over-year.
  • Guardant Health, Inc. Amortization of Intangible Assets for the twelve months ending March 31, 2024 was $2.7 M, unchanged year-over-year.
  • Guardant Health, Inc. annual Amortization of Intangible Assets for 2023 was $2.7 M, a 8% increase from 2022.
  • Guardant Health, Inc. annual Amortization of Intangible Assets for 2022 was $2.5 M, a 31.6% increase from 2021.
  • Guardant Health, Inc. annual Amortization of Intangible Assets for 2021 was $1.9 M, a 5.56% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.7 M $700 K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.7 M $600 K -$100 K -14.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $2.8 M $700 K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $2.8 M $700 K +$100 K +16.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $2.7 M $700 K +$200 K +40% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $2.5 M $700 K +$300 K +75% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $2.2 M $700 K +$200 K +40% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $2 M $600 K +$100 K +20% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $1.9 M $500 K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $1.9 M $400 K -$200 K -33.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $2.1 M $500 K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $2.1 M $500 K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $2.1 M $500 K +$300 K +150% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $1.8 M $600 K +$300 K +100% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $1.5 M $500 K +$300 K +150% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $1.2 M $500 K +$300 K +150% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $900 K $200 K +$200 K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $700 K $300 K +$994 K Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 -$294 K $200 K -$66 K -24.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$228 K $200 K -$39 K -16.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$189 K $0 -$189 K -100% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $0 -$694 K Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $266 K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $239 K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $189 K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.